At the beginning of a new trading week, it is often essential for investors to take a look at what went on in the previous week and hence, it might be a good move to look into the Regen BioPharma (OTCMKTS:RGBP) stock.
The stock made a strong move on Friday and rallied by 13% to end the week with gains of as much as 75%. Last week the company had announced that in the period that ended in September last year, it had no cash balance. However, in the prior year period, it held cash to the tune of $7885.
The reduction in the cash balance was primarily a function of the money that had been spent on operations. In this context, it is perhaps also necessary to keep in mind that at the end of the period in September 2020, the company got account receivable to the tune of $103,192. The account receivables in the prior year period had been $71,186. The rise in account receivables had been brought about by the anniversary fees and royalties that Regen had been paid by Zander. Those fees totalled as much as $27,424. It now remains to be seen if the stock continues to rally today.
